CAMBRIDGE, Mass.--(BUSINESS WIRE)--Imara Inc. today announced it will report additional preclinical and Phase 1 clinical data from the company’s lead compound, IMR-687, a once-daily, oral therapy ...
You can see the IMR in action here too. Sledgehammer Games explains how they developed the quasi-real, quasi-fantasy weaponry of Call of Duty: Advanced Warfare. In particular, they revealed one weapon ...
Final data from 93-patient Phase 2a clinical trial show lower annualized rate of vaso-occlusive crises (VOCs) and longer time to first VOC on IMR-687 Interim open-label extension clinical trial data ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback